These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 36047595)
1. Multidrug-Resistant and Extremely Drug-Resistant Awanye AM; Ibezim CN; Stanley CN; Onah H; Okonko IO; Egbe NE Turk J Pharm Sci; 2022 Aug; 19(4):447-454. PubMed ID: 36047595 [TBL] [Abstract][Full Text] [Related]
2. Distribution of the Strains of Multidrug-resistant, Extensively Drug-resistant, and Pandrug-resistant Hosseininassab Nodoushan SA; Yadegari S; Moghim S; Isfahani BN; Fazeli H; Poursina F; Nasirmoghadas P; Safaei HG Adv Biomed Res; 2017; 6():74. PubMed ID: 28706882 [TBL] [Abstract][Full Text] [Related]
3. Frequency and antibiogram of multi-drug resistant pseudomonas aeruginosa in a Tertiary Care Hospital of Pakistan. Farooq L; Memon Z; Ismail MO; Sadiq S Pak J Med Sci; 2019; 35(6):1622-1626. PubMed ID: 31777504 [TBL] [Abstract][Full Text] [Related]
4. Incidence of multidrug resistant pseudomonas aeruginosa isolated from burn patients and environment of teaching institution. Biswal I; Arora BS; Kasana D; Neetushree J Clin Diagn Res; 2014 May; 8(5):DC26-9. PubMed ID: 24995179 [TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibility patterns of clinical isolates of Samad A; Ahmed T; Rahim A; Khalil A; Ali I Pak J Med Sci; 2017; 33(3):670-674. PubMed ID: 28811792 [TBL] [Abstract][Full Text] [Related]
6. Detection of Multidrug Resistant (MDR) and Extremely Drug Resistant (XDR) P. Aeruginosa Isolated from Patients in Tehran, Iran. Saderi H; Owlia P Iran J Pathol; 2015; 10(4):265-71. PubMed ID: 26351496 [TBL] [Abstract][Full Text] [Related]
7. Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas aeruginosa in a tertiary care hospital. Raja NS; Singh NN J Microbiol Immunol Infect; 2007 Feb; 40(1):45-9. PubMed ID: 17332906 [TBL] [Abstract][Full Text] [Related]
8. Multidrug-Resistance Genes in Pseudomonas aeruginosa from Wound Infections in a Tertiary Health Institution in Osogbo, Nigeria. Akinloye AO; Adefioye JO; Adekunle CO; Anomneze BU; Makanjuola OB; Onaolapo OJ; Onaolapo AY; Olowe OA Infect Disord Drug Targets; 2021; 21(1):90-98. PubMed ID: 31957616 [TBL] [Abstract][Full Text] [Related]
9. Antimicrobial Resistance Profile of Asamenew T; Worku S; Motbainor H; Mekonnen D; Deribe A Ethiop J Health Sci; 2023 May; 33(3):423-432. PubMed ID: 37576170 [TBL] [Abstract][Full Text] [Related]
10. Clinical Specimens are the Pool of Multidrug- resistant Pseudomonas aeruginosa Harbouring oprL and toxA Virulence Genes: Findings from a Tertiary Hospital of Nepal. Chand Y; Khadka S; Sapkota S; Sharma S; Khanal S; Thapa A; Rayamajhee B; Khadka DK; Panta OP; Shrestha D; Poudel P Emerg Med Int; 2021; 2021():4120697. PubMed ID: 34745664 [TBL] [Abstract][Full Text] [Related]
11. Changing Trend in the Antibiotic Resistance Pattern of Pseudomonas Aeruginosa Isolated from Wound Swabs of Out-Patients and in-Patients of a Tertiary Care Hospital. Joseph NM; Devi S; Shashikala P; Kanungo R J Clin Diagn Res; 2013 Oct; 7(10):2170-2. PubMed ID: 24298467 [TBL] [Abstract][Full Text] [Related]
12. Detection of Antibiotic Resistance Genes Among Multiple Drug Resistant Pseudomonas Aeruginosa Isolated from Clinical Sources in Selected Health Institutions in Kwara State. Adekunle C; Mustapha A; Odewale G; Richard O Infect Disord Drug Targets; 2021; 21(6):e170721187999. PubMed ID: 33200719 [TBL] [Abstract][Full Text] [Related]
13. Detection of synergistic antimicrobial resistance mechanisms in clinical isolates of Pseudomonas aeruginosa from post-operative wound infections. Awan AB; Yan A; Sarwar Y; Schierack P; Ali A Appl Microbiol Biotechnol; 2021 Dec; 105(24):9321-9332. PubMed ID: 34797390 [TBL] [Abstract][Full Text] [Related]
14. Successfully controlling the incidence of multidrug-resistant Pseudomonas aeruginosa through antibiotic stewardship and infection control programmes at a Chinese university hospital. Li QY; Liu B; Liu L J Clin Pharm Ther; 2021 Oct; 46(5):1357-1366. PubMed ID: 34096086 [TBL] [Abstract][Full Text] [Related]
15. In vitro efficacy of colistin against multi-drug resistant Pseudomonas aeruginosa by minimum inhibitory concentration. Gill MM; Rao JU; Kaleem F; Hassan A; Khalid A; Anjum R Pak J Pharm Sci; 2013 Jan; 26(1):7-10. PubMed ID: 23261721 [TBL] [Abstract][Full Text] [Related]
16. High incidence of MDR and XDR Pseudomonas aeruginosa isolates obtained from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part of the MagicBullet clinical trial. Pérez A; Gato E; Pérez-Llarena J; Fernández-Cuenca F; Gude MJ; Oviaño M; Pachón ME; Garnacho J; González V; Pascual Á; Cisneros JM; Bou G J Antimicrob Chemother; 2019 May; 74(5):1244-1252. PubMed ID: 30753505 [TBL] [Abstract][Full Text] [Related]
17. [Antibiotic susceptibility rates and beta-lactam resistance mechanisms of Pseudomonas aeruginosa strains]. Aktaş Z; Satana D; Kayacan C; Can B; Gönüllü N; Küçükbasmacı O Mikrobiyol Bul; 2012 Jul; 46(3):386-97. PubMed ID: 22951651 [TBL] [Abstract][Full Text] [Related]
18. High prevalence of multidrug-resistant Akrami S; Ekrami A; Jahangirimehr F; Yousefi Avarvand A Health Sci Rep; 2024 Jun; 7(6):e2164. PubMed ID: 38903659 [TBL] [Abstract][Full Text] [Related]
19. Inducible Amp C Beta-lactamase producing Pseudomonas aeruginosa: Predominant Resistance Mechanism and a Threat in a Tertiary Care Teaching Hospital. Mp N; Bv N J Assoc Physicians India; 2019 Apr; 67(4):63-66. PubMed ID: 31299842 [TBL] [Abstract][Full Text] [Related]
20. Incidence and Molecular Characterization of Carbapenemase Genes in Association with Multidrug-Resistant Clinical Isolates of Pseudomonas aeruginosa from Tertiary Healthcare Facilities in Southwest Nigeria. Olaniran OB; Adeleke OE; Donia A; Shahid R; Bokhari H Curr Microbiol; 2021 Dec; 79(1):27. PubMed ID: 34905085 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]